Suppr超能文献

胸膜内纤维蛋白溶解剂联合影像引导下胸腔闭式引流治疗胸膜感染。

Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.

作者信息

Levinson Gary M, Pennington Daniel W

机构信息

Mercy Medical Center of North Iowa, 1000 4th St SW, Mason City, IA 50401, USA.

出版信息

Mayo Clin Proc. 2007 Apr;82(4):407-13. doi: 10.4065/82.4.407.

Abstract

OBJECTIVE

To present our method of treating pleural infection by using a combination of image-guided chest tube drainage and intrapleural fibrinolytics.

PATIENTS AND METHODS

We retrospectively reviewed the medical charts and radiographs of 30 consecutive patients with pleural infection who were seen at our institution from December 15, 1995, to July 1, 2006, 27 of whom received intrapleural urokinase or tissue-type plasminogen activator. End points were death, length of stay in the hospital, and percentage of patients who needed surgery.

RESULTS

Placement of chest tubes required image guidance 45.7% of the time. Three patients (10%; 95% confidence interval, 2.1%-26.5%) died of complications from pleural infection. None of the 30 patients (0%; 95% confidence interval, 0%-9.5%) required surgery for treatment of pleural infection. The median hospital length of stay was 11 days.

CONCLUSIONS

In the treatment of pleural infection, intrapleural urokinase or tissue-type plasminogen activator in combination with careful image-guided placement of chest tubes is highly effective in resolving the effusion and curing the infection.

摘要

目的

介绍我们采用影像引导下胸腔置管引流联合胸腔内使用纤维蛋白溶解剂治疗胸腔感染的方法。

患者与方法

我们回顾性分析了1995年12月15日至2006年7月1日在我院就诊的30例连续性胸腔感染患者的病历和X光片,其中27例接受了胸腔内尿激酶或组织型纤溶酶原激活剂治疗。观察终点为死亡、住院时间及需要手术治疗的患者比例。

结果

45.7%的胸腔置管操作需要影像引导。3例患者(10%;95%置信区间,2.1%-26.5%)死于胸腔感染并发症。30例患者中无一例(0%;95%置信区间,0%-9.5%)因胸腔感染需要手术治疗。中位住院时间为11天。

结论

在胸腔感染的治疗中,胸腔内使用尿激酶或组织型纤溶酶原激活剂并结合影像引导下仔细放置胸腔引流管,在消除胸腔积液和治愈感染方面非常有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验